Tr. Rebbeck et al., Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat, AM J HU GEN, 64(5), 1999, pp. 1371-1377
Citations number
25
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Compared with the general population, women who have inherited a germline m
utation in the BRCA1 gene have a greatly increased risk of developing breas
t cancer. However, there is also substantial interindividual variability in
the occurrence of breast cancer among BRCA1 mutation carriers. We hypothes
ize that other genes, particularly those involved in endocrine signaling, m
ay modify the BRCA1-associated age-specific breast cancer risk. We studied
the effect of the CAG repeat-length polymorphism found in exon 1 of the and
rogen-receptor (AR) gene (AR-CAG). AR alleles containing longer CAG repeat
lengths are associated with a decreased ability to activate androgen-respon
sive genes. Using a sample of women who inherited germline BRCA1 mutations,
we compared AR-CAG repeat length in 165 women with and 139 women without b
reast cancer. We found that women were at significantly increased risk of b
reast cancer if they carried at least one AR allele with greater than or eq
ual to 28 CAG repeats. Women who carried an AR-CAG allele of greater than o
r equal to 28, greater than or equal to 29, or greater than or equal to 30
repeats were given a diagnosis 0.8, 1.8, or 6.3 years earlier than women wh
o did not carry at least one such allele. All 11 women in our sample who ca
rried at least one AR-CAG allele with greater than or equal to 29 repeats h
ad breast cancer. Our results support the hypothesis that age at breast can
cer diagnosis is earlier among BRCA1 mutation carriers who carry very long
AR-CAG repeats. These results suggest that pathways involving androgen sign
aling may affect the risk of BRCA1-associated breast cancer.